Site Map

Botulinum toxin injection - larynx

Injection laryngoplasty; Botox - larynx: spasmodic dysphonia - BTX; Essential voice tremor (EVT) - btx; Glottic insufficiency; Percutaneous electromyography-guided botulinum toxin treatment; Percutaneous indirect laryngoscopy-guided botulinum toxin treatment; Adductor dysphonia - BTX; OnabotulinumtoxinA - larynx; AbobotulinumtoxinA

Botulinum toxin (BTX) is a type of nerve blocker. When injected, BTX blocks nerve signals to muscles so they relax.

BTX is the toxin that causes botulism, a rare but serious illness. It is safe when used in very small doses.

Description

BTX is injected into the muscles around the vocal cords. This weakens the muscles and improves voice quality. It is not a cure for laryngeal dystonia, but can help ease the symptoms.

In most cases, you will have the BTX injections in your health care provider's office. There are two common ways to inject BTX into the larynx:

Through the neck:

Through the mouth:

Why the Procedure Is Performed

You would have this procedure if you have been diagnosed with laryngeal dystonia. BTX injections are the most common treatment for this condition.

BTX injections are used to treat other problems in the voice box (larynx). They are also used to treat many other conditions in different parts of the body.

After the Procedure

You may not be able to talk for about an hour after the injections.

BTX can cause some side effects. In most cases, these side effects only last a few days. Some of the side effects include:

Outlook (Prognosis)

In most cases, BTX injections should improve your voice quality for about 3 to 4 months. To maintain your voice, you may need injections every few months.

Your provider may ask you to keep a diary of your symptoms to see how well and how long the injection is working. This will help you and your provider find the right dose for you and to decide how often you need treatment.

References

Akst L. Hoarseness and laryngitis. In: Kellerman RD, Rakel DP, Heidelbaugh JJ, Lee EM, eds. Conn's Current Therapy 2023. Philadelphia, PA: Elsevier; 2023:28-33.

Blitzer A, Kirke DN. Neurologic disorders of the larynx. In: Flint PW, Francis HW, Haughey BH, et al, eds. Cummings Otolaryngology: Head and Neck Surgery. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 57.

Flint PW. Throat disorders. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 401.

BACK TO TOP

Review Date: 11/29/2022  

Reviewed By: Josef Shargorodsky, MD, MPH, Johns Hopkins University School of Medicine, Baltimore, MD. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo
Health Content Provider
06/01/2025

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complied with the HONcode standard for trustworthy health information from 1995 to 2022, after which HON (Health On the Net, a not-for-profit organization that promoted transparent and reliable health information online) was discontinued.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.